FindTrial
Sign In

liposomal cytarabine-daunorubicin CPX-351

DRUG2 trials

Sponsors

Fred Hutchinson Cancer Center, Rondeep Brar

Conditions

Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaAdult Acute Erythroid Leukemia (M6)Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)Adult Acute Myeloblastic Leukemia With Maturation (M2)Adult Acute Myeloblastic Leukemia Without Maturation (M1)

Phase 2

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
CompletedNCT02019069
Rondeep BrarAdult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) +13
Start: 2014-02-03End: 2017-12-18Updated: 2019-01-22

Unknown Phase

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
CompletedNCT01804101
Fred Hutchinson Cancer CenterAcute Biphenotypic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome +1
Start: 2013-05-07End: 2017-01-10Updated: 2018-05-25